BGI’s CEO ZHAO Li said in an interview that China will lead, for years to come, the global market for human genetic testing. Her market share at present is 60 %, but national screening programs are strongly rising as well; thus millions of Chinese women will undergo genetic testing for human papilloma virus infections, available at a cost of 100 Yuan by genetic testing.

China Industrial Biotechnology Network, March 12, 2013